HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CpG ODN 2006

ODN - oligodeoxyribonucleotide

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleotides: 15763
  - Polynucleotides: 218
    - Oligonucleotides: 5145
      - Oligodeoxyribonucleotides: 2217
        CpG ODN 2006: 2

Experts

1.	Cho, Elizabeth L: 1 article (01/2021)
2.	Krivoshik, Sara R: 1 article (01/2021)
3.	Nehete, Bharti P: 1 article (01/2021)
4.	Nehete, Pramod N: 1 article (01/2021)
5.	Patel, Akash G: 1 article (01/2021)
6.	Pei, Xuewei: 1 article (01/2021)
7.	Ramani, Margish D: 1 article (01/2021)
8.	Scholtzova, Henrieta: 1 article (01/2021)
9.	Shao, Yongzhao: 1 article (01/2021)
10.	Williams, Lawrence E: 1 article (01/2021)

Related Diseases

1.	Inflammation (Inflammations) 01/01/2021 - "We demonstrate that long-term use of Class B CpG ODN 2006 induces a favourable degree of innate immunity stimulation without producing excessive or sustained inflammation, resulting in efficient amelioration of both CAA and tau Alzheimer's disease-related pathologies in association with behavioural improvements and in the absence of microhaemorrhages in aged elderly squirrel monkeys. "
2.	Hyperplasia 01/01/2001 - "We examined the effect of a potent human CpG oligonucleotide (CpG ODN 2006) on different types of primary human malignant B cells and reactive follicular hyperplasia. "
3.	Alzheimer Disease (Alzheimer's Disease) 01/01/2021 - "We demonstrate that long-term use of Class B CpG ODN 2006 induces a favourable degree of innate immunity stimulation without producing excessive or sustained inflammation, resulting in efficient amelioration of both CAA and tau Alzheimer's disease-related pathologies in association with behavioural improvements and in the absence of microhaemorrhages in aged elderly squirrel monkeys. "

Related Drugs and Biologics

1.	CPG-oligonucleotide